Viewing Study NCT05394493


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2025-12-25 @ 11:28 PM
Study NCT ID: NCT05394493
Status: COMPLETED
Last Update Posted: 2023-12-06
First Post: 2022-05-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: An Observational Chart Review Study To Describe The Real-World Outcomes And Use Of Avelumab In Combination With Axitinib For Treatment Of Patients With aRCC In The UK
Sponsor: Pfizer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-06-11
Start Date Type: ACTUAL
Primary Completion Date: 2023-08-30
Primary Completion Date Type: ACTUAL
Completion Date: 2023-08-30
Completion Date Type: ACTUAL
First Submit Date: 2022-05-23
First Submit QC Date: None
Study First Post Date: 2022-05-27
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-11-29
Last Update Post Date: 2023-12-06
Last Update Post Date Type: ACTUAL